Physician

Manlio Adam Goetzl, M.D.

According to 2025 Medicare claims, Manlio Goetzl, M.D. (NPI: 1932229853) practices urology in the Pinehurst-Southern Pines, NC market, with the plurality of this provider's patient population coming from Moore, NC. This provider's primary affiliated billing organization is PINEHURST SURGICAL CLINIC PA (NPI: 1962434324; TIN: 560942061) and primary practice location at 28374-9495. Goetzl is affiliated with the Carolinas HealthCare System ACO, LLC (ACO ID: A3675), participating under the MSSP model.

Goetzl's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 788 traditional Medicare patients, billed 7,172 HCPCS/CPT codes, and received $304,539 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,845 prescription claims across 741 beneficiaries totaling $1,049,551 in drug costs, led by Xtandi (Enzalutamide). DME data shows 109 claims. Open Payments data shows 27 records totaling $661. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $65,378 to $1,049,551. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,155 to $552.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	691	5,752	$249,288
2016	739	6,077	$285,125
2017	891	8,201	$365,938
2018	873	8,850	$366,140
2019	971	9,811	$358,038
2020	987	8,973	$388,420
2021	864	10,048	$375,154
2022	811	7,806	$311,156
2023	787	7,493	$302,894
2024	788	7,172	$304,539

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	300	1,283	$65,378
2016	337	1,460	$79,102
2017	439	1,883	$124,806
2018	485	2,219	$199,422
2019	529	2,214	$243,254
2020	609	2,458	$286,141
2021	616	2,328	$412,659
2022	616	2,411	$881,436
2023	689	2,582	$762,929
2024	741	2,845	$1,049,551

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	37	98	$5,886
2016	26	153	$17,888
2017	73	266	$18,727
2018	71	344	$16,482
2019	59	322	$18,664
2020	71	326	$13,410
2021	52	309	$14,731
2022	30	208	$10,963
2023	N/R	72	$20,390
2024	N/R	109	$20,956

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	318	523	$85
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	497	667	$59
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	451	651	$11
36415	Insertion of needle into vein for collection of blood sample	270	362	$9
81001	Manual urinalysis test with examination using microscope, automated	306	394	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	58	1,740	$794,505
Gemtesa	Vibegron	155	6,008	$94,000
Myrbetriq	Mirabegron	128	6,286	$92,226
Tamsulosin Hcl	Tamsulosin Hcl	834	67,495	$12,649
Estradiol	Estradiol	53	2,812	$7,967

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	28	$13,214
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	42	$7,340
A4332	Lubricant, individual sterile packet, each	N	N/R	39	$402

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$661	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Manlio Adam Goetzl, M.D.?

Tedicare shows public-source Medicare data for Manlio Adam Goetzl, M.D. (NPI 1932229853), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Manlio Adam Goetzl, M.D. have ACO affiliation data?

Manlio Adam Goetzl, M.D. is shown with ACO affiliation data for Carolinas HealthCare System ACO, LLC (MSSP, ACO ID A3675).

What billing organization is linked to Manlio Adam Goetzl, M.D.?

Manlio Adam Goetzl, M.D. is linked to PINEHURST SURGICAL CLINIC PA (billing NPI 1962434324) in the available physician profile data.

Does Manlio Adam Goetzl, M.D. have Open Payments data?

Manlio Adam Goetzl, M.D. has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.